Cowles Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Gestalt provides a vendor-neutral digital pathology platform and professional services that enable pathology laboratories and health systems to modernize workflows, integrate AI tools, and manage diagnostic imaging without vendor lock-in.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSpokane, US
Steve Rector(Executive Officer)inKen McCabe(Executive Officer, Director)Dan Roark(Executive Officer, Director, Promoter)
BoardBill Driscoll(Director)Chris Patrick(Director)Octavio Morales(Director)
Co-investorsSun Mountain CapitalKickstartTacoma Venture Fund
Qualterra provides molecular plant testing services for horticultural and agricultural operations, including virus screening, variety verification, and genomic analysis.
AgTechBiotechPullman, US
Mike Werner(Executive Officer, Director)inAmit Dhingra(Director)
BoardSteve Rector(Director)inBob McCambridge(Director)Kirk Washington(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





